BioRegenx, Inc.
BRGX
$0.01
-$0.0039-28.06%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.24M | -20.17M | -23.05M | -4.91M | -7.03M |
| Total Depreciation and Amortization | 1.20M | 1.73M | 2.22M | 1.65M | 1.07M |
| Total Amortization of Deferred Charges | 23.20K | 38.00K | 47.70K | 33.40K | 24.80K |
| Total Other Non-Cash Items | 17.59M | 17.73M | 19.93M | 2.54M | 5.03M |
| Change in Net Operating Assets | 430.90K | 484.80K | 530.60K | 137.60K | 92.40K |
| Cash from Operations | -1.70K | -182.20K | -324.20K | -558.40K | -810.70K |
| Capital Expenditure | 0.00 | 0.00 | -189.40K | -189.40K | -189.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 1.40K | 1.40K | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.30K | 2.70K | 0.00 | -202.10K | -202.10K |
| Cash from Investing | -47.30K | 2.70K | -187.90K | -390.00K | -390.00K |
| Total Debt Issued | 88.30K | 190.40K | 490.40K | 491.50K | 505.90K |
| Total Debt Repaid | -42.40K | -41.20K | -48.20K | -56.10K | -64.10K |
| Issuance of Common Stock | -- | -- | -- | 527.10K | 590.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.90K | 149.20K | 442.20K | 962.50K | 1.03M |
| Foreign Exchange rate Adjustments | -7.90K | -200.00 | 2.90K | -2.00K | 600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.00K | -30.60K | -67.00K | 12.10K | -168.00K |